High rates of recurrent biliary tract obstruction in children with sickle cell disease

Martha O. Amoako, James F Casella, John Strouse

Research output: Contribution to journalArticle

Abstract

Background: Individuals with sickle cell disease (SCD) have an increased risk of cholelithiasis from bilirubin stones. Symptomatic biliary tract disease (BTD) includes acute and chronic cholecystitis, obstruction of the common bile duct (CBD), cholangitis, and gallstone pancreatitis. Cholecystectomy is the main treatment strategy for symptomatic patients; however, the prevalence of recurrent BTD following cholecystectomy has not been systematically evaluated. We conducted a retrospective cohort study to describe the recurrence of BTD after cholecystectomy and characterize risk factors for recurrent disease. Procedure: We identified patients

Original languageEnglish (US)
Pages (from-to)650-652
Number of pages3
JournalPediatric Blood and Cancer
Volume60
Issue number4
DOIs
StatePublished - Apr 2013

Fingerprint

Biliary Tract Diseases
Biliary Tract
Sickle Cell Anemia
Cholecystectomy
Acute Cholecystitis
Cholangitis
Cholelithiasis
Gallstones
Bilirubin
Pancreatitis
Cohort Studies
Retrospective Studies
Recurrence
Therapeutics

Keywords

  • Cholangitis
  • Cholecystitis
  • Sickle cell disease

ASJC Scopus subject areas

  • Oncology
  • Pediatrics, Perinatology, and Child Health
  • Hematology

Cite this

High rates of recurrent biliary tract obstruction in children with sickle cell disease. / Amoako, Martha O.; Casella, James F; Strouse, John.

In: Pediatric Blood and Cancer, Vol. 60, No. 4, 04.2013, p. 650-652.

Research output: Contribution to journalArticle

@article{759f3289c0bc45f5b42714ce6f6f4096,
title = "High rates of recurrent biliary tract obstruction in children with sickle cell disease",
abstract = "Background: Individuals with sickle cell disease (SCD) have an increased risk of cholelithiasis from bilirubin stones. Symptomatic biliary tract disease (BTD) includes acute and chronic cholecystitis, obstruction of the common bile duct (CBD), cholangitis, and gallstone pancreatitis. Cholecystectomy is the main treatment strategy for symptomatic patients; however, the prevalence of recurrent BTD following cholecystectomy has not been systematically evaluated. We conducted a retrospective cohort study to describe the recurrence of BTD after cholecystectomy and characterize risk factors for recurrent disease. Procedure: We identified patients",
keywords = "Cholangitis, Cholecystitis, Sickle cell disease",
author = "Amoako, {Martha O.} and Casella, {James F} and John Strouse",
year = "2013",
month = "4",
doi = "10.1002/pbc.24413",
language = "English (US)",
volume = "60",
pages = "650--652",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - High rates of recurrent biliary tract obstruction in children with sickle cell disease

AU - Amoako, Martha O.

AU - Casella, James F

AU - Strouse, John

PY - 2013/4

Y1 - 2013/4

N2 - Background: Individuals with sickle cell disease (SCD) have an increased risk of cholelithiasis from bilirubin stones. Symptomatic biliary tract disease (BTD) includes acute and chronic cholecystitis, obstruction of the common bile duct (CBD), cholangitis, and gallstone pancreatitis. Cholecystectomy is the main treatment strategy for symptomatic patients; however, the prevalence of recurrent BTD following cholecystectomy has not been systematically evaluated. We conducted a retrospective cohort study to describe the recurrence of BTD after cholecystectomy and characterize risk factors for recurrent disease. Procedure: We identified patients

AB - Background: Individuals with sickle cell disease (SCD) have an increased risk of cholelithiasis from bilirubin stones. Symptomatic biliary tract disease (BTD) includes acute and chronic cholecystitis, obstruction of the common bile duct (CBD), cholangitis, and gallstone pancreatitis. Cholecystectomy is the main treatment strategy for symptomatic patients; however, the prevalence of recurrent BTD following cholecystectomy has not been systematically evaluated. We conducted a retrospective cohort study to describe the recurrence of BTD after cholecystectomy and characterize risk factors for recurrent disease. Procedure: We identified patients

KW - Cholangitis

KW - Cholecystitis

KW - Sickle cell disease

UR - http://www.scopus.com/inward/record.url?scp=84873704545&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873704545&partnerID=8YFLogxK

U2 - 10.1002/pbc.24413

DO - 10.1002/pbc.24413

M3 - Article

C2 - 23255346

AN - SCOPUS:84873704545

VL - 60

SP - 650

EP - 652

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 4

ER -